Interim scan during prostate cancer therapy helps guide treatment

New prostate cancer research shows that adding an interim scan during therapy can help guide a patient's treatment. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging of patients with metastatic castration-resistant prostate cancer after two cycles of lutetium-177 (177Lu)-PSMA radioligand therapy has shown a significant predictive value for patient survival.

from Latest Science News -- ScienceDaily http://bit.ly/2x9t52T

Comments

Popular posts from this blog

SpaceX wants to launch 100,000 Starlink satellites to orbit

On this day in space! Oct. 28, 1971: Britain launches its 1st satellite Prospero into space on a Black Arrow rocket